The therapy of low levels of high density lipoprotein-cholesterol / 医学研究生学报

ABSTRACT

High density lipoprotein(HDL) is an antiatherogenetic lipoprotein and low level of HDL-cholesterol(HDL-C) in plasma is a risk factor for coronary heart disease.Therefore,raising the level of HDL-C by pharmaceuticals,oestrogen replacement and biologic therapy for dyslipidemia exhibit great clinical significance.